Preliminary results of educate, a multicenter, community-based, open-label study of the effect of etanercept on skin and joint disease in patients with psoriatic arthritis - 21/08/11
Alice Gottlieb, MD, PhD, University of Medicine and Dentistry of New Jersey–Robert Wood Johnson Medical School, New Brunswick, NJ, United States; Steven Grekin, DO, Desmoines University College of Medicine, Warren, MI, United States; James Maloney, MD, Cherry Creek Dermatology, Denver, CO, United States; Seth Stevens, MD, Amgen Inc., Thousand Oaks, CA, United States
Le texte complet de cet article est disponible en PDF. P2780 Dr. Gottlieb is an investigator, consultant, and member of the speaker bureau for Amgen Inc. Drs. Grekin and Maloney have no financial conflicts of interest to disclose. Supported by Immunex Corporation, a wholly owned subsidiary of Amgen Inc., and by Wyeth Research |
Vol 52 - N° 3S
P. P191 - mars 2005 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?